Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Heart Transplant Failure and Rejection: full-pipeline trial registry
2 of 6 indexed Heart Transplant Failure and Rejection trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Heart Transplant Failure and Rejection: 6 US clinical trials tracked, 2 recruiting.
Heart Transplant Failure and Rejection is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Paul Kim, running 1 of these trials.
Enrollment posture brief
Registry condition heart-transplant-failure-and-rejection
OPEN 2 | RECR 33% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Heart Transplant Failure and Rejection lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Heart Transplant Failure and Rejection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Heart Transplant Failure and Rejection is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Heart Transplant Failure and Rejection research.
Paul Kim accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Heart Transplant Failure and Rejection enrolment sits around 196 participants.
Median target enrolment is 196 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Heart Transplant Failure and Rejection splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Allograft Dysfunction in Heart Transplant
Paul Kim
NCT03102125
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Columbia University
NCT07079735
A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy
Natera
NCT06414603
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
University of British Columbia
NCT03575910
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
University of Utah
NCT04380311
Bioelectrical Impedance Spectroscopy in Heart Transplantation: Tracking Post-Transplant Changes in Body Composition and Correlation With Conventional Preoperative Risk Assessment Modalities
Baylor Research Institute
NCT03373279
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Heart Transplant Failure and Rejection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Heart Transplant Failure and Rejection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Heart Transplant Failure and Rejection page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Heart Transplant Failure and Rejection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Paul Kim sponsors the most Heart Transplant Failure and Rejection trials on record, review their full trial history before evaluating a specific study. See Paul Kim's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heart Transplant Failure and Rejection condition card totals 6 registered trials; most-linked intervention Tacrolimus Dosing Support Tool; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.